Table 1 Phenotyping and biochemical analysis for T2DM patients and control groups
Parameter | Control | T2DM subject | P value |
|---|---|---|---|
No. (M/F) | 400 (196/204) | 400 (192/208) | – |
Age (year) | 53.72 ± 11.19 | 53.68 ± 13.79 | 0.96 |
BMI (kg/m2) | 25.33 ± 2.10 | 29.53 ± 2.98 | < 0.0001 |
FBS (mg/dl) | 104.32 ± 7.88 | 228.65 ± 35.92 | < 0.0001 |
Cholesterol (mg/dl) | 188.87 ± 17.61 | 254.93 ± 26.42 | < 0.0001 |
Triglyceride (mg/dl) | 135.73 ± 18.39 | 236.77 ± 24.20 | < 0.0001 |
VLDL-C (mg/dl) | 27.15 ± 3.67 | 47.35 ± 4.84 | < 0.0001 |
LDL-C (mg/dl) | 106.89 ± 11.55 | 164.81 ± 14.64 | < 0.0001 |
HDL-C (mg/dl) | 54.83 ± 8.21 | 42.76 ± 9.11 | < 0.0001 |
Insulin (μU/ml) | 12.93 ± 2.61 | 32.85 ± 3.83 | < 0.0001 |
HOMA-IR | 3.33 ± 0.82 | 18.54 ± 1.92 | < 0.0001 |